Sveriges mest populära poddar
Oncology Today with Dr Neil Love
Hälsa och motionMedicin

For Oncology Nurses: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from the 2026 Annual ONS Congress

1 tim 30 min•1 juli 2026

Featuring perspectives from Dr Alexandra Drakaki, Ms Krisztina Emodi, Dr Terence Friedlander and Ms Margarita Huober, moderated by Dr Friedlander, including the following topics:

  • Introduction: Basic Biology of Nonmetastatic Urothelial Bladder Cancer (UBC) (0:00)
  • Systemic Therapy for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer (MIBC) (13:35)
  • Evolving Approach to Systemic Therapy for Cisplatin-Ineligible Patients with MIBC (37:13)
  • Immune Checkpoint Inhibitors in Non-Muscle-Invasive Bladder Cancer (58:55)
  • Novel Intravesical Therapies for Nonmetastatic UBC (1:10:20)

NCPD information and select publications

Fler avsnitt av Oncology Today with Dr Neil Love

Visa alla avsnitt av Oncology Today with Dr Neil Love
Targeted Therapies for Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit
•50 min
HR-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit
•1 tim 39 min
Acute Myeloid Leukemia — Fifth Annual National General Medical Oncology Summit
•52 min
Desmoid Tumors and Soft Tissue Sarcoma — Fifth Annual National General Medical Oncology Summit
•51 min
EGFR-Mutated Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit
•51 min
Metastatic Triple-Negative Breast Cancer — What Clinicians Want to Know
•54 min
Urothelial Bladder Cancer — Year in Review Series on Relevant New Datasets and Advances
•58 min
Myelofibrosis and Systemic Mastocytosis — Fifth Annual National General Medical Oncology Summit
•51 min
For Oncology Nurses: Endometrial Cancer — Proceedings from the 2026 Annual ONS Congress
•1 tim 28 min
HER2-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit
•52 min

Oncology Today with Dr Neil Love med Dr. Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.